Evidence map›Paper›PMID 32066749›Full record

ArticleScientific reports2020

Screening of inmates transferred to Spain reveals a Peruvian prison as a reservoir of persistent Mycobacterium tuberculosis MDR strains and mixed infections.

Estefanía Abascal, Marta Herranz, Fermín Acosta, Juan Agapito, Andrea M Cabibbe, Johana Monteserin, María Jesús Ruiz Serrano, Paloma Gijón, Francisco Fernández-González, Nuria Lozano and 11 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. SpecificMicroorganisms · 2024
    Article
  6. Article
  7. Characteristic SNPs defining the major multidrug-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  8. Tuberculosis in Spain: An opinion paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 5 countries.

Estefanía AbascalHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Marta HerranzHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Fermín AcostaHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Juan AgapitoTB Research Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Andrea M CabibbeEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID http://orcid.org/0000-0001-9727-6465
Johana MonteserinInstituto Nacional de Enfermedades Infecciosas INEI-ANLIS, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
María Jesús Ruiz SerranoHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Paloma GijónHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Francisco Fernández-GonzálezHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Nuria LozanoHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Álvaro Chiner-OmsUnidad Mixta Genómica y Salud, Centro Superior de Investigación en Salud Pública (FISABIO)-Universitat de València, Valencia, Spain.
Tatiana CáceresTB Research Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Pilar Gómez PintadoGeneral Subdirection of Penitentiary Health - Penitentiary Institutions - Ministry of Interior of Spain, Madrid, Spain.
Enrique AcínGeneral Subdirection of Penitentiary Health - Penitentiary Institutions - Ministry of Interior of Spain, Madrid, Spain.
Eddy ValenciaInstituto Nacional de Salud, Lima, Peru.
Patricia MuñozHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Iñaki ComasInstituto de Biomedicina de Valencia (IBV) Consejo Superior de Investigaciones Científicas (CSIC), Valencia, Spain.ORCID http://orcid.org/0000-0001-5504-9408
Daniela M CirilloEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Viviana RitaccoInstituto Nacional de Enfermedades Infecciosas INEI-ANLIS, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
Eduardo GotuzzoTB Research Unit, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Darío García de ViedmaHospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. dgviedma2@gmail.com.
Hospital General Universitario Gregorio Marañón · ESUniversidad Peruana Cayetano Heredia · PEConsejo Nacional de Investigaciones Científicas y Técnicas · ARFederal Penitentiary Service · RUVita-Salute San Raffaele University · ITConsejo Superior de Investigaciones Científicas · ESInstituto Nacional de Salud · PEUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is relevant to evaluate MDR-tuberculosis in prisons and its impact on the global epidemiology of this disease. However, systematic molecular epidemiology programs in prisons are lacking. A health-screening program performed on arrival for inmates transferred from Peruvian prisons to Spain led to the diagnosis of five MDR-TB cases from one of the biggest prisons in Latin America. They grouped into two MIRU-VNTR-clusters (Callao-1 and Callao-2), suggesting a reservoir of two prevalent MDR strains. A high-rate of overexposure was deduced because one of the five cases was coinfected by a pansusceptible strain. Callao-1 strain was also identified in 2018 in a community case in Spain who had been in the same Peruvian prison in 2002-5. A strain-specific-PCR tailored from WGS data was implemented in Peru, allowing the confirmation that these strains were currently responsible for the majority of the MDR cases in that prison, including a new mixed infection.

Indexed as

PrisonersAntitubercular AgentsBacterial Typing TechniquesCoinfectionDrug Resistance, Multiple, BacterialHumansMass ScreeningMolecular EpidemiologyMycobacterium tuberculosisPatient TransferPeruPrevalencePrisonsSpainTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryAntitubercular Agents

Identifiers

PMID32066749
PMCPMC7026066
OpenAlexW3006084034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.